Current Oncology Reports
Q1 Journal
Journal
Country
United States
Northern America
Subject Area and Category
Medicine
└
Oncology
Q1
Publisher
SJR 2025
1.595
Q1
SJR Score
H-Index
91
Citations / Doc (2yr)
5.46
Total Docs. (latest)
113
Total Citations (3yr)
2,555
Publication type
Journals
ISSN
15346269, 15233790
Coverage
1999-2026
Journal Rank
#2,170
Subject Categories
Oncology
Q1
Subject Areas
Aims & Scope
This journal aims to review the most important, recently published clinical findings in the field of oncology.
By providing clear, insightful, balanced contributions by international experts, the journal intends to serve all those involved in the care of those affected by cancer.
We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as cancer prevention, leukemia, melanoma, neuro-oncology, and palliative medicine.
Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists.
An international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research.
Commentaries from well-known figures in the field are also provided.
Abstracting & Indexing
Scopus
Google Scholar
Web of Science
Medline
Embase
Detailed Metrics
| Total Docs. (latest) | 113 |
| Total Docs. (3 years) | 447 |
| Total Refs. | 10,016 |
| Total Citations (3 years) | 2,555 |
| Citable Docs. (3 years) | 446 |
| Citations / Doc. (2 years) | 5.46 |
| Ref. / Doc. | 88.64 |
| % Female | 44.8% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Loading trend data from Crossref...
Top 10 Most Cited Articles
Loading articles...
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.